Cancer drugs
These companies develop or sell medicines that treat cancer, such as pills, antibodies and cell therapies.
+44.3%
over 1 year · S&P 500 +11.6%
Key indicators
Health
49 / 100
Fragile
Solid
Price
P/E 40
Cheap
Expensive
Up over 1 year
57 of 105
Wallets over 90 days
2 / 5 buys / sells
Buys
Sells
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 113 companies
LLY
+42.7%
JNJ
+50.3%
ABBV
+29.5%
MRK
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
L
Eli Lilly
LLY
33.3%
+42.7%
J
Johnson & Johnson
JNJ
16.5%
+50.3%
A
AbbVie
ABBV
12.9%
+29.5%
M
Merck
MRK
9.0%
+66.3%
A
Amgen
AMGN
6.2%
+42.3%
G
Gilead Sciences
GILD
5.2%
+39.6%
P
Pfizer
PFE
4.1%
+19.1%
B
Bristol-Myers Squibb
BMY
3.1%
+35.0%
R
Regeneron Pharmaceuticals
REGN
2.3%
+40.9%
M
Moderna
MRNA
2.2%
+736.3%
R
Revolution Medicines
RVMD
1.1%
+161.7%
I
Incyte
INCY
0.6%
+11.7%
E
Exelixis
EXEL
0.4%
+58.3%
S
Summit Therapeutics
SMMT
0.3%
−24.9%
C
Corcept Therapeutics
CORT
0.2%
−7.0%
I
ImmunityBio
IBRX
0.2%
+192.2%
C
CG Oncology
CGON
0.2%
+88.8%
E
Erasca
ERAS
0.1%
+490.9%
C
Cogent Biosciences
COGT
0.1%
−19.0%
L
Legend Biotech
LEGN
<0.1%
−43.9%
R
Relay Therapeutics
RLAY
<0.1%
+193.2%
T
Tango Therapeutics
TNGX
<0.1%
+232.5%
E
Enliven Therapeutics
ELVN
<0.1%
+140.4%
I
Iovance Biotherapeutics
IOVA
<0.1%
+205.5%
P
Parabilis Medicines
PBLS
<0.1%
C
Celcuity
CELC
<0.1%
−24.4%
I
IDEAYA Biosciences
IDYA
<0.1%
−0.4%
X
Xencor
XNCR
<0.1%
+157.7%
R
Arcus Biosciences
RCUS
<0.1%
−12.9%
B
Biohaven
BHVN
<0.1%
+73.8%
I
Immunome
IMNM
<0.1%
+7.7%
R
Recursion Pharmaceuticals
RXRX
<0.1%
−31.5%
R
Replimune Group
REPL
<0.1%
+142.1%
V
Vir Biotechnology
VIR
<0.1%
+74.4%
Z
Zymeworks
ZYME
<0.1%
+35.5%
S
SELLAS Life Sciences
SLS
<0.1%
+427.5%
P
Precigen
PGEN
<0.1%
+12.9%
N
Nurix Therapeutics
NRIX
<0.1%
+27.2%
N
Nuvation Bio
NUVB
<0.1%
−19.1%
T
Tyra Biosciences
TYRA
<0.1%
+29.4%
D
Damora Therapeutics
DMRA
<0.1%
−8.5%
I
Inhibrx
INBX
<0.1%
+13.6%
V
Verastem
VSTM
<0.1%
−3.9%
C
Corvus Pharmaceuticals
CRVS
<0.1%
+30.1%
A
Aktis Oncology
AKTS
<0.1%
O
Oric Pharmaceuticals
ORIC
<0.1%
−37.0%
S
Syndax Pharmaceuticals
SNDX
<0.1%
−43.7%
R
Rigel Pharmaceuticals
RIGL
<0.1%
+11.3%
O
Obsidian Therapeutics
OBX
<0.1%
A
Aura Biosciences
AURA
<0.1%
+27.6%
S
Sana Biotechnology
SANA
<0.1%
−50.2%
C
Cullinan Therapeutics
CGEM
<0.1%
+23.1%
F
Fulgent Genetics
FLGT
<0.1%
−15.2%
N
Nuvectis Pharma
NVCT
<0.1%
+236.8%
D
Delcath Systems
DCTH
<0.1%
+139.2%
K
Kura Oncology
KURA
<0.1%
−27.2%
C
Candel Therapeutics
CADL
<0.1%
+26.0%
O
Olema Pharmaceuticals
OLMA
<0.1%
−6.2%
J
Janux Therapeutics
JANX
<0.1%
−60.1%
B
Bicara Therapeutics
BCAX
<0.1%
−32.8%
A
ArriVent BioPharma
AVBP
<0.1%
−35.6%
G
Geron
GERN
<0.1%
−22.0%
C
Crescent Biopharma
CBIO
<0.1%
+8.4%
M
Monopar Therapeutics
MNPR
<0.1%
−12.8%
C
CytomX Therapeutics
CTMX
<0.1%
−51.8%
B
BlossomHill Therapeutics
BLSM
<0.1%
A
Arvinas
ARVN
<0.1%
−34.5%
R
Relmada Therapeutics
RLMD
<0.1%
+7.7%
P
Puma Biotechnology
PBYI
<0.1%
+55.7%
C
C4 Therapeutics
CCCC
<0.1%
+11.3%
F
Faeth Therapeutics
FTH
<0.1%
−0.7%
E
Eikon Therapeutics
EIKN
<0.1%
A
Agenus
AGEN
<0.1%
+51.9%
A
Allogene Therapeutics
ALLO
<0.1%
−31.8%
I
Immuneering
IMRX
<0.1%
−44.0%
C
Cypherpunk Technologies
CYPH
<0.1%
−8.8%
Z
Zentalis Pharmaceuticals
ZNTL
<0.1%
+26.9%
S
Sutro Biopharma
STRO
<0.1%
+21.1%
A
ALX Oncology
ALXO
<0.1%
−18.8%
F
Fate Therapeutics
FATE
<0.1%
+23.1%
I
Inovio Pharmaceuticals
INO
<0.1%
−27.0%
P
PDS Biotechnology
PDSB
<0.1%
−9.5%
C
Perspective Therapeutics
CATX
<0.1%
−55.5%
C
Corbus Pharmaceuticals
CRBP
<0.1%
−69.7%
A
Acrivon Therapeutics
ACRV
<0.1%
−36.4%
A
ABVC BioPharma
ABVC
<0.1%
−69.6%
A
Actuate Therapeutics
ACTU
<0.1%
−95.5%
A
Allarity Therapeutics
ALLR
<0.1%
−24.9%
A
AIM ImmunoTech
AIM
<0.1%
−64.1%
B
BioAtla
BCAB
<0.1%
−95.0%
A
Ascentage Pharma Group International
AAPG
−55.6%
A
Adagene
ADAG
−3.4%
A
ADC Therapeutics
ADCT
−66.9%
A
Adlai Nortye
ANL
+559.0%
A
Autolus Therapeutics
AUTL
−14.0%
A
AstraZeneca
AZN
B
BioNTech
BNTX
−23.4%
E
Electra Therapeutics
ETRA
G
Genmab
GMAB
+68.6%
G
GSK
GSK
+8.6%
H
HUTCHMED
HCM
−2.5%
I
Iambic Therapeutics
IAM
I
Immunocore
IMCR
−15.2%
I
Immatics
IMTX
−40.1%
J
Jazz Pharmaceuticals
JAZZ
+76.7%
N
Nanobiotix
NBTX
+42.1%
N
Novartis
NVS
+23.7%
O
BeOne Medicines
ONC
+10.4%
R
Roche Holdings
RHHBY
+21.9%
T
Takeda Pharmaceutical
TAK
+54.2%
T
Telix Pharmaceuticals
TLX
−5.9%
U
UroGen Pharma
URGN
+4.1%
Z
Zai Lab
ZLAB
+12.4%